I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
The names of the study interventions involved in this study are: Sacituzumab govitecan (IMMU-132) Pembrolizumab (Keytruda; MK-3475)
immunomodulators
keytruda
liver metastasis
periodic abstinence
measurable disease
- 8 views
- 05 Aug, 2020
A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma
This is a non-randomized Phase 2 study of sacituzumab govitecan (IMMU-132) in subjects with persistent or recurrent endometrial carcinoma.
major surgery
ct scan
carcinoma
neuropathy
liver metastasis
- 0 views
- 16 Feb, 2024
- 1 location